Long-term Use of Cholinesterase Inhibitors: Till Death do Us part?
Authors:
- 10 February 2011
- journal article
- Published by Taylor & Francis in Neurodegenerative Disease Management
- Vol. 1 (1) , 7-9
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease – a multicentre RCTTrials, 2009
- Persistence with Cholinesterase Inhibitor Therapy for DementiaDrugs & Aging, 2009
- Review: Therapy for Alzheimer's disease: how effective are current treatments?Therapeutic Advances in Neurological Disorders, 2009
- Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementiaThe American Journal of Geriatric Pharmacotherapy, 2009
- Diagnosis and treatment of dementia: 6. Management of severe Alzheimer diseaseCanadian Medical Association Journal, 2008
- Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementiaCanadian Medical Association Journal, 2008
- Discontinuation of donepezil for the treatment of Alzheimer's disease in geriatric practiceInternational Psychogeriatrics, 2008
- The Use of a Cholinesterase Inhibitor Review Committee in Long-Term CareJournal of the American Medical Directors Association, 2007
- Naturalistic audit of NICE criteria for the use of cholinesterase inhibitorsPsychiatric Bulletin, 2005
- Drug Persistency of Two Cholinesterase InhibitorsDrugs & Aging, 2005